EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunolocalization of Kisspeptin Associated with Amyloid- β Deposits in the Pons of an Alzheimer’s Disease Patient

Amrutha Chilumuri, Maria Ashioti, Amanda N. Nercessian, Nathaniel G. N. Milton

Journal of Neurodegenerative Diseases · 2013

DOI: 10.1155/2013/879710 ↗
AbstractBibliografische Angaben

Abstract

The pons region of the Alzheimer’s disease (AD) brain is one of the last to show amyloid- β (A β ) deposits and has been suggested to contain neuroprotective compounds. Kisspeptin (KP) is a hormone that activates the hypothalamic-pituitary-gonadal axis and has been suggested to be neuroprotective against A β toxicity. The localization of KP, plus the established endogenous neuroprotective compounds corticotropin releasing hormone (CRH) and catalase, in tissue sections from the pons region of a male AD subject has been determined in relation to A β deposits. Results showed A β deposits also stained with KP, CRH, and catalase antibodies. At high magnification the staining of deposits was either KP or catalase positive, and there was only a limited area of the deposits with KP-catalase colocalization. The CRH does not bind A β , whilst both KP and catalase can bind A β , suggesting that colocalization in A β deposits is not restricted to compounds that directly bind A β . The neuroprotective actions of KP, CRH, and catalase were confirmed in vitro , and fibrillar A β preparations were shown to stimulate the release of KP in vitro. In conclusion, neuroprotective KP, CRH, and catalase all colocalize with A β plaque-like deposits in the pons region from a male AD subject.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →